Loading Please Wait...

Agilent TapeStation

The Lab901 ScreenTape system is a revolutionary tape-based platform for simpler, faster and more reliable gel electrophoresis. Place your sample tubes and ScreenTape consumable in the TapeStation and let it load, separate, image, analyse and present the results. Pre-packaged, enclosed reagents and full automation mean ScreenTape is safer, reproducible and reduces lab waste.
Includes Combined TapeStation instrument, laptop, software packages, accessories, and start-up service.
Feature Overview:
- Automated sample loading, electrophoresis and imaging
- 2 x 8 strip tubes or 96-well plate compatible
- Loads from minimum of 3uL
- Uses 0.2uL to 0.7uL of prepared sample
- Easy-to-use controller

Human Periodontal Disease Array Q1

Quantibody® Human Periodontal Disease Array 1 Kit.

Screen 20 key inflammatory and bone metabolic factors associated with active periodontal disease:
CRP, IFNg, IL-1a, IL-1b, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-17, MIP-1a, MMP-9, MMP-13, OPG, OPN, Osteoactivin, RANK, TGFb1, TNFa


View the video below for how to perform Quantibody array experiment:

TransIT®-BrCa Transfection Reagent

TransIT®-BrCa Transfection Reagent is the first dedicated breast cancer cell line specific reagent available to researchers today. While it delivers efficiently to many breast cancer cell types, it also maintains low cellular toxicity resulting in reduced experimental biases.


  • Broad Spectrum DNA Delivery - Achieve high expression levels in breast cancer cell types including: MCF-7, MDA-MB-231, MDA-MB-453, MDA-MB-468, and T47D.
  • Formulated for Low Cellular Toxicity - Maintain cell density and reduce experimental biases due to toxicity.
  • Superior Transfection Efficiency - TransIT®-BrCa outperforms Lipofectamine® 2000, in multiple breast cancer cell lines.

A short video on youtube highlighting TransIT®-BrCa transfection reagent:

TRANSCREENER ADP2 FP Assay

Transcreener ADP2 FP Assay uses a highly sensitive antibody against ADP and a far red tracer to produce an excellent signal at less than 10% ATP consumption for a broad range of initial ATP concentrations (0.1-1,000 µM). Both reagents and signal are stable at room temperature for over 24 hours providing outstanding flexibility for automated high-volume screening programs. Used in over 40M wells of pharma screening since 2006, Transcreener is the most extensively validated ADP detection method available backed by the best technical support in the industry.
Signup for